Regulation & Compliance

A new VAB report alleges Nielsen's 'Big Data + Panel' currency is unstable and inaccurate, revealing massive audience variances that threaten media deals.

An exclusive Miami summit gathers top investors and CEOs to heed a stark warning: embrace the AI disruption or face extinction. What will they decide?

A major foundation is investing $75.8M to build a responsible public architecture for AI, funding projects that prioritize human rights and global equity.

The iGaming supplier launches 80 exclusive games in Brazil's new regulated market, a strategic move to capture growth in Latin America's largest economy.

VIAVI Solutions converts over $100 million in debt to stock, a strategic move to reduce leverage and prepay a major loan after a recent acquisition.

Annexus and Athene are embedding complex academic theories into new retirement products. But can they deliver on the promise of safer returns for investors?

New clinically aware AI agents offer empathetic, 24/7 patient support, aiming to reduce provider burnout and improve access to care for all.

ViaBill's Apple Pay integration brings new financing to Danish checkout, but this convenience arrives amid new regulations and a major strategy shift from Apple.

Ayrmid and RoslinCT forge a key manufacturing pact for a new SAA therapy, revealing the critical infrastructure needed for resilient biotech returns.

A $1.2M investment isn't just charity; it's a strategic push for 'whole-person health' aimed at fixing the Pacific Northwest's deepest care gaps.

As browsers become the enterprise OS, a new security frontier emerges. Analyst firm Frost & Sullivan crowns Seraphic a leader in Zero Trust Browser Security.

New law ends decades of uncertainty for 'Lost Canadians' and modernizes rules for passing on citizenship to children born abroad.

Sweeping reforms pulled Florida's property insurance market from the brink of collapse. We decode the fixes, the capital influx, and the risks that still loom.

AECOM's win on the GSA OASIS+ contract is more than a deal; it's a strategic move reshaping federal services and securing its role in national projects.

A new law requires work verification for millions on Medicaid. One tech firm has a solution, but can its AI bridge the gap or widen the access divide?

A Minneapolis firm is testing a graft that helps the body rebuild its own arteries. This could end a painful, risky part of traditional heart bypass surgery.

Natera's legal retreat solidifies a major victory for NeoGenomics, clearing the runway for its RaDaR ST launch and shaking the diagnostic patent landscape.

Vanda Pharmaceuticals submits its novel GPP therapy, imsidolimab, for FDA review, offering new hope for patients and bolstering its rare disease portfolio.

JCDecaux's new AI measures MTR audiences with precision, but can it win public trust by balancing data insights with total anonymity?

A new AI system deters birds to prevent avian flu. But its real innovation lies in data, transforming biosecurity from a costly chore into a profitable investment.